J. Safra Sarasin Holding Ag Regeneron Pharmaceuticals, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $6.19 Trillion
- Q3 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 2,303 shares of REGN stock, worth $1.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,303
Previous 562
309.79%
Holding current value
$1.6 Million
Previous $295 Million
338.88%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,468Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...